新型冠状病毒肺炎诊治要点浅析

doi:10.3969/j.issn.2095-3755.2020.01.003

结核病与肺部健康杂志 ›› 2020, Vol. 9 ›› Issue (1): 7-10.doi: 10.3969/j.issn.2095-3755.2020.01.003

新型冠状病毒肺炎诊治要点浅析

邓国防, 雷建平()

518112 国家感染性疾病临床医学研究中心深圳市第三人民医院肺二科(邓国防);江西省胸科医院结核科(雷建平)

收稿日期:2020-03-10 出版日期:2020-03-30 发布日期:2020-04-17
通信作者: 邓国防,雷建平 E-mail:lei-jianping@vip.sina.com

Analysis on diagnosis and treatment of coronavirus disease 2019(COVID-19)

DENG Guo-fang, LEI Jian-ping()

^*National Clinical Research Center for Infectious Disease, Pulmonary Diseases Department Two, Shenzhen Third People’s Hospital, Shenzhen 518112, China

Received:2020-03-10 Online:2020-03-30 Published:2020-04-17
Contact: DENG Guo-fang,LEI Jian-ping E-mail:lei-jianping@vip.sina.com

摘要/Abstract

摘要：

当前新型冠状病毒肺炎(简称“新冠肺炎”)在中国引起严重疫情,而且对世界公共卫生造成巨大压力。截至发稿之日,全国确诊人数已逾8万例,全球超过10万例。为更好地增强临床医师对新冠肺炎的认识,我们结合新冠肺炎临床一线的救治体会、相关发表的研究文献和最近的诊疗方案,给大家简要概述新冠肺炎的诊治要点。期望能给临床医生提供一定的参考作用。

关键词: 新型冠状病毒肺炎, 诊断,鉴别, 疾病特征, 药物疗法, 方案评价, 评论

Abstract:

The novel coronavirus pneumonia (also named as coronavirus disease 2019 (COVID-19) By WHO) has been causing a severe public health problem in China. Now the epidemic has been posing great emergency not only in China, but also to the public health system worldwide. More than 80000 confirmed cases in China and more than 100000 confirmed cases worldwide have been reported at the day of this manuscript. For enhancing the clinicians’ understanding of COVID-19, we briefly summarized some main points of diagnosis and treatment from our experiences of COVID-19 patients care, literature review and recent diagnosis and treatment regimen. We hope to provide some references to clinicians when taking care of COVID-19 patients.

Key words: Coronavirus disease 2019 (COVID-19), Diagnosis, differential, Disease attributes, Drug therapy, Program evaluation, Comment

邓国防, 雷建平. 新型冠状病毒肺炎诊治要点浅析[J]. 结核病与肺部健康杂志, 2020, 9(1): 7-10. doi: 10.3969/j.issn.2095-3755.2020.01.003

DENG Guo-fang, LEI Jian-ping. Analysis on diagnosis and treatment of coronavirus disease 2019(COVID-19)[J]. Journal of Tuberculosis and Lung Health, 2020, 9(1): 7-10. doi: 10.3969/j.issn.2095-3755.2020.01.003

参考文献 13

[1]	World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance[EB/OL]. 2020- 01- 28. [2020-01-30]. .
[2]	中华人民共和国国家卫生健康委员会办公厅,中华人民共和国国家中医药管理局办公室. 关于印发新型冠状病毒肺炎诊疗方案(试行第七版)的通知[EB/OL]. 国卫办医函〔2020〕184号. 2020- 03- 03. [2020-03-05]. .
[3]	Xu Z, Shi L, Wang Y , et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med, 2020. pii: S2213-2600(20)30076-X. doi: 10.1016/S2213-2600(20) 30076-X.[Epub ahead of print].
[4]	Wang D, Hu B, Hu C , et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA, 2020. doi: 10.1001/jama.2020.1585.[Epub ahead of print].
[5]	Luo W, Yu H, Gou J , et al. Clinical pathology of critical patient with novel coronavirus pneumonia (COVID-19)[J/OL]. Preprints,2020: 2020020407. 2020-02-17. [2020-02-26]. .
[6]	Chen N, Zhou M, Dong X , et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 2020,395(10223):507-513.
[7]	Guo L, Wei D, Zhang X , et al. Clinical features predicting mortality risk in patients with viral pneumonia: The MuLBSTA score. Front Microbiol, 2019,10:2752. doi: 10.3389/fmicb.2019.02752.eCollection 2019.
[8]	Li Q, Guan X, Wu P , et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med, 2020. doi: 10.1056/NEJMoa2001316.[Epub ahead of print].
[9]	Huang C, Wang Y, Li X , et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 2020,395(10223):497-506.
[10]	Chan JF, Yuan S, Kok KH , et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet, 2020,395(10233):514-523.
[11]	刘又宁 . 关于新型冠状病毒感染疾病治疗药物的思考[J/OL]. 中华结核和呼吸杂志,2020,43. 2020-02-18.[2020-02-26]. .
[12]	赵建平, 胡轶, 杜荣辉 , 等. 新型冠状病毒肺炎糖皮质激素使用的建议[J/OL]. 中华结核和呼吸杂志,2020,43. 2020-02-08.[2020-02-26]. .
[13]	高占成, . 科学认识和科学管理是防控和救治新型冠状病毒肺炎的关键 [J/OL]. 中华结核和呼吸杂志,2020,43. 2020-02-05. [2020-02-21]. .

[1]	黄进宝, 兰长青, 吕骁, 陈璐璐, 王新航, 陈玉榕, 黄明翔. 国外输入性新型冠状病毒肺炎23例诊疗经验分析[J]. 结核与肺部疾病杂志, 2020, 1(3): 213-219.
[2]	刘伯飞, 王芳, 刘伯霞, 马玉杰, 冯涛, 徐麟, 赵桂霞, 洪苑, 刘广天, 周攀, 曹相原. 84例新型冠状病毒肺炎患者CT表现与免疫学指标的变化特点分析[J]. 结核与肺部疾病杂志, 2020, 1(3): 220-225.
[3]	林明贵, 林金兰, 魏来, 张萍, 周碧琴, 张文砚, 华昊, 赵文静, 聂广孟, 苏立楠, 王小辉, 陈凯丽. 新型冠状病毒感染疫情期间以发热门诊为核心的综合医院防控策略[J]. 结核与肺部疾病杂志, 2020, 1(2): 109-111.
[4]	沈聪, 焦磊, 白璐, 张毅力, 郭佑民. 新型冠状病毒肺炎患者肺部CT病变质量及外周血淋巴细胞计数的动态演变分析[J]. 结核与肺部疾病杂志, 2020, 1(2): 126-130.
[5]	靳民路, 常蕴青, 齐凤鸣, 关晓岗, 郑冠华, 赵永华, 李震强, 李孝生, 王利芬, 王芳, 白印杰. 39例新型冠状病毒肺炎患者的临床特点及疗效分析[J]. 结核与肺部疾病杂志, 2020, 1(2): 131-135.
[6]	王颖, 蔡春葵, 许岩, 孙诗学, 李刚, 顾晓峰, 于洋. 利奈唑胺治疗广泛耐药肺结核疗效分析[J]. 结核与肺部疾病杂志, 2020, 1(2): 136-139.
[7]	余艳艳, 陈振华, 王珏, 闾艳, 陈忠南, 刘彬彬, 易松林, 胡培磊, 谭云洪. 痰培养阳性肺结核并发非结核分枝杆菌肺病患者的临床特征及影响因素[J]. 结核与肺部疾病杂志, 2020, 1(2): 144-148.
[8]	王利花, 刘燕燕. 27例神经型布鲁杆菌病的临床分析[J]. 结核与肺部疾病杂志, 2020, 1(2): 183-185.
[9]	彭鹏, 余辉山, 周新华. 新型冠状病毒肺炎的临床特点与CT诊断价值[J]. 结核病与肺部健康杂志, 2020, 9(1): 11-15.
[10]	余辉山, 秦立新, 丁晨宇, 刘静, 李宝学, 李政旻. 250例新型冠状病毒肺炎高分辨率CT特征分析[J]. 结核病与肺部健康杂志, 2020, 9(1): 19-24.
[11]	黄毅, 王思翰, 郑楚云, 刘月, 张耀辉. 新型冠状病毒肺炎患者不同发病时期肺周病变超声成像表现的初步探讨[J]. 结核病与肺部健康杂志, 2020, 9(1): 25-31.
[12]	蒋玲, 罗廷茹, 周小琦, 唐娜, 蒙昌平, 钱春芳. 含利奈唑胺化疗方案治疗重症结核性脑膜炎的效果评价[J]. 结核病与肺部健康杂志, 2020, 9(1): 44-48.
[13]	宋敏, 方伟军, 韩远远, 冯惠勇. 儿童耐药肺结核的CT特征分析[J]. 结核病与肺部健康杂志, 2020, 9(1): 58-63.
[14]	李荣, 马进宝, 任斐, 张帆, 谭淦纹, 周婕, 武延琴. 初治涂阳肺结核患者营养状况与胸部CT表现的关联性研究[J]. 结核与肺部疾病杂志, 2020, 1(1): 17-23.
[15]	毛毅, 陈怡, 吴桂辉, 陈静. 肺结核患者营养风险与临床特征的相关性分析[J]. 结核与肺部疾病杂志, 2020, 1(1): 24-28.

新型冠状病毒肺炎诊治要点浅析

Analysis on diagnosis and treatment of coronavirus disease 2019(COVID-19)

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 13

相关文章 15

编辑推荐

Metrics

本文评价

友情链接